NCT07663201Not yet recruiting
Cardiovascular Risk in Patients With IBD
Dissecting the Complexity of Inflammatory Bowel Disease (IBD) A Prospective Study With Focus on Cardiovascular Risk
Source: ClinicalTrials.gov · Last updated 16 Oct 2026
Brief summary (registry, in English)
In this study the Research Hospital San Donato Policlinic ask the participation with the aim to evaluate the risk of cardiovascular complication (i.e. stroke, myocardial infarction) in patients with inflammatory bowel disease. Multiple parameters (therapy, disease activity, life style) and investigations (DNA, stool, lab tests) will be evaluate with the support of artificial intelligence methodologies to better define the cardiovascular risk.
- Status (registry)
- Not yet recruiting
- Study type
- Observational
- Enrollment
- 300 (estimated)
- First submitted
- 17 Jun 2026
- Start date
- 1 Sept 2026
- Primary completion date
- 31 Aug 2029
- Lead sponsor
- IRCCS Policlinico S. Donato
- NCT number
- NCT07663201
What you commit to
- Study type: Observational
- Planned participants: 300
- From 1 Sept 2026 to the primary completion date, 31 Aug 2029
- No sites listed in no country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Age
- Age \> 18 years Not compliant with study protocol
Who the study is looking for
- Established diagnosis of ulcerative colitis and Crohn's disease
Age in the registry: 18 years to - · Sex: All · Accepts healthy volunteers
This page is information, not medical advice. Discuss any trial with your doctor.